Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Bupropion Products
NCT02078180Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Apr 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupropion in major depressive disorder (MDD) (6 arms), sponsored by University of Michigan. Primary endpoint: Area Under the Concentration Time Curve. Started Apr 2014; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02078180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078180.